MHRA Blog - Summer 2025

11th August 2025

MHRA MedRegs Blog – Summer 2025: Updates on Regulatory Reform and Innovation

The MHRA has outlined significant strides in regulatory reform to enhance patient access to innovative medical technologies. Key developments include the introduction of new reliance pathways for medical devices approved in the US, Canada, and Australia, facilitating faster market entry in Great Britain. Additionally, the agency is consulting on the indefinite recognition of CE-marked products to streamline regulatory processes.

These initiatives align with the government's 10 Year Health Plan and Life Sciences Sector Plan, emphasising the role of science and technology in transforming healthcare delivery. The MHRA is also advancing its Innovative Devices Access Pathway (IDAP) and AI Airlock programmes to support the safe and rapid evaluation of emerging medical technologies. 

For more details, read the full blog post: MHRA MedRegs Blog – Summer 2025

Back to Recent News